Survival outcomes for first-line antiretroviral therapy in India's ART program.

MLA

Dandona, Rakhi, et al. “Survival Outcomes for First-Line Antiretroviral Therapy in India’s ART Program.” BMC Infectious Diseases, vol. 16, no. 1, Oct. 2016, p. 555. EBSCOhost, https://doi.org/10.1186/s12879-016-1887-2.

APA

Dandona, R., Rewari, B. B., Kumar, G. A., Tanwar, S., Kumar, S. G. P., Vishnumolakala, V. S., Duber, H. C., Gakidou, E., & Dandona, L. (2016). Survival outcomes for first-line antiretroviral therapy in India’s ART program. BMC Infectious Diseases, 16(1), 555. https://doi.org/10.1186/s12879-016-1887-2

Chicago

Dandona, Rakhi, Bharat B Rewari, G Anil Kumar, Sukarma Tanwar, S G Prem Kumar, Venkata S Vishnumolakala, Herbert C Duber, Emmanuela Gakidou, and Lalit Dandona. 2016. “Survival Outcomes for First-Line Antiretroviral Therapy in India’s ART Program.” BMC Infectious Diseases 16 (1): 555. doi:10.1186/s12879-016-1887-2.